News

Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments

The 2022 Prize for Translational Infection Research of the German Center for Infection Research (DZIF), endowed with 5,000 euros, goes to the DZIF scientist and epidemiologist Gérard Krause. Prof

Dr. Victoria Ingham, a scientist at Heidelberg Medical Faculty and the German Center for Infection Research (DZIF), has been awarded an ERC Starting Grant of 1.5 million euro for her research on the

Stephan Urban, DZIF professor at Heidelberg University Hospital, receives the Baruch S. Blumberg Prize 2023 from the Hepatitis B Foundation, a global non-profit organisation. The virologist is being

This year again, from November 18 to 24, attention is being drawn worldwide to the threatening increase in resistance to antibiotics and other antimicrobial agents. The World Health Organisation (WHO)

Between 10 and 20 million people worldwide are infected with hepatitis D virus (HDV). HDV infection is always associated with hepatitis B virus infection. So far there has been no satisfactory

Tuberculosis is one of the leading causes of death worldwide, with an estimated 1.4 million deaths and ten million people infected annually. Resistant and multidrug-resistant (MDR) variants of the

In the early 20th century, French scientists Albert Calmette and Camille Guérin developed a vaccine from the bovine tuberculosis bacterium Mycobacterium bovis, which was named BCG (Bacillus Calmette

Finding active agents against SARS-CoV-2 and other coronaviruses—this goal has been pursued by DZIF scientist Prof Thomas Schulz and his team at Hannover Medical School (MHH) since the virus first

Besides SARS-CoV and SARS-CoV-2, the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is among the highly pathogenic coronaviruses that can lead to severe respiratory disease and death. It is